510(k) K222601
K222601 is an FDA 510(k) premarket notification submitted by Biofire Diagnostics, LLC for the device "FilmArray Pneumonia Panel plus". The FDA issued a decision of Substantially Equivalent on Oct 27, 2022. The device falls under product code QDS (Mers-Cov And Common Respiratory Pathogens Semi-Quantitative And Quantitative Multiplex Nucleic Acid Detection System), a Class II device regulated under 21 CFR 866.4001. Biofire Diagnostics, LLC has 37 other 510(k) clearances on record.
Clearance details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- Oct 27, 2022
- Date Received
- Aug 29, 2022
- Clearance Type
- Special
- Expedited Review
- No
- Third Party Review
- No
Device classification
- Device Name
- Mers-Cov And Common Respiratory Pathogens Semi-Quantitative And Quantitative Multiplex Nucleic Acid Detection System
- Device Class
- Class II
- Regulation Number
- 866.4001
- Review Panel
- MI
- Submission Type
- 510(k)
A Middle East Respiratory Syndrome Coronavirus (MERS-CoV) and common respiratory pathogens qualitative, semi-quantitative or quantitative multiplex nucleic acid detection system is an in vitro diagnostic test for the detection, identification, and quantification of MERS-CoV and common respiratory pathogens associated nucleic acids in human clinical specimens. The test is indicated for individuals meeting specific MERS-CoV clinical and/or epidemiological criteria. It aids in the differential diagnosis of MERS-CoV infection in conjunction with other clinical, epidemiologic, and laboratory data, in accordance with the guidelines provided by the appropriate public health authorities.
Need the full FDA record for Biofire Diagnostics, LLC? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.